- Home
- Companies
- Axial Therapeutics Inc.
- News
- Axial Therapeutics to Participate in a ...
Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci Capital
Source: Axial Therapeutics Inc.
WALTHAM, Mass. -- Axial Therapeutics Inc., a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that company management will participate in a fireside chat hosted by LifeSci Capital on Tuesday, November 17, 2020 at 1:00 PM ET.
About Axial Therapeutics
Axial Therapeutics is a clinical-stage, biopharmaceutical company pioneering novel science focused on the interaction between the brain and the gut to mitigate the causes and symptoms of the central nervous system and other gut-derived diseases. The Company has built a pipeline of novel small molecules with lead programs to address the significant unmet patient needs associated with Parkinson’s Disease and Autism Spectrum Disorder.
Customer comments
No comments were found for Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci Capital. Be the first to comment!